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ABSTRACT
Objectives: Intrahepatic cholestasis of pregnancy is the most common pregnancy specific liver disease and related with 
adverse maternal and perinatal outcome. Red blood cell distribution width, an anisocytosis marker in a complete blood 
count, has been used as an inflammation marker in various diseases. However the association of red blood cell distribution 
width with intrahepatic cholestasis of pregnancy is unknown. We aimed to evaluate the relationship between red blood 
cell distribution width and intrahepatic cholestasis of pregnancy. 
Material and methods: Ninety pregnant women with intrahepatic cholestasis of pregnancy and ninety healthy pregnant 
women were included in the study. Their clinical and laboratory characteristics including red blood cell distribution width, 
liver function tests, fasting and postprandial bile acid concentrations were analyzed.
Results: Serum red blood cell distribution width cell levels were significantly higher in pregnants with intrahepatic choles-
tasis of pregnancy than healthy pregnants. We also demonstrated that red blood cell distribution Width levels were higher 
in severe disease than mild disease and was significantly correlated with fasting and postprandial bile acid concentration 
in intrahepatic cholestasis of pregnancy group. 
Conclusions: Our study showed that red blood cell distribution width, an easy and inexpensive marker; were associated 
with intrahepatic cholestasis of pregnancy and can be used as a diagnostic and prognostic marker in intrahepatic chol-
estasis of pregnancy. 
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INTRODUCTION 
Intrahepatic cholestasis of pregnancy (ICP) is the most 
common pregnancy specific liver disease and presents 
mainly in the third trimester with pruritis, elevated total 
serum bile acids and raised liver enzymes [1]. The incidence 
of the disease is reported between 0.2% and 2% depending 
on geographical location and ethnicity [2, 3]. ICP has been 
associated with serious and adverse pregnancy outcome 
such as preterm birth, nonreassuring fetal heart tracing, 
meconium staining of the amniotic fluid, and stillbirth [4].
The etiology of the ICP is complex and has not yet been 
understood. Multiple factors such as cholestatic effect of 
reproductive hormones in genetically susceptible preg-
nants, dietary and environmental factors play role in the 
pathogenesis of the disease [5, 6]. The association between 
inflammatory processes and cholestatic liver disease has 
been reported in previous studies [5, 7]. Elevated concentra-
tions of bile acids (BA) may lead to inflammatory response 
characterized by infiltration of inflammatory cells in hepato-
cytes and cause hepatocellular injury [5]. 
Red cell distribution width (RDW) is evaluated automati-
cally during complete blood count (CBC) and shows vari-
ation of red blood cell volume. It is an anisocytosis marker 
and used especially for differential diagnosis of anemia 
[8]. However recent studies reported that systemic inflam-
mation may lead to increase in RDW levels and it can be 
used as an inflammation marker in various diseases such 
as cardiovascular diseases (CVD), hypertension (HT), and 
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thrombotic disorders [9]. Furthermore RDW is reported to 
be an independent risk factor for death in general popula-
tion [10]. 
Although there are studies showing an association be-
tween RDW and many diseases associated with inflamma-
tion, there is no data about RDW levels and its relationship 
with ICP. Therefore we aimed to evaluate if there is an as-
sociation between serum RDW levels and ICP and also with 
disease severity. 
MATERIAL AND METHODS
This prospective case-control study was conducted 
at the Zekai Tahir Burak Women’s Health Education and 
Research Hospital, a tertiary center in Ankara, Turkey. The 
Institutional Review Board of the hospital approved the 
study, and the universal principles of the Helsinki Declara-
tion were applied. Informed consent was obtained from all 
participants.
Ninety pregnant women with diagnosis of ICP, 53 with 
mild disease and 27 with severe disease, during the period of 
January 2014 and January 2016 were included to the study. 
Ninety healthy pregnant women matched for maternal age 
in the third trimester within the same time were recruited 
as the control group. Pregnant with active infection, with 
chronic systemic disease (endocrinological, urogenital, car-
diovascular, gastrointestinal, immunological, or oncological) 
and with multiple gestation were excluded from study. ICP 
was defined when the pregnant had unexplained pruritis 
without rashes in different parts of body with elevated se-
rum TBA (≥ 10 mmol/L) and/or raised liver enzymes. Preg-
nant women with ICP were divided into mild and severe 
group based on serum TBA levels of 10–40 and ≥ 40 mmol/L, 
respectively [1]. All the pregnant women with ICP were hos-
pitalized and tested for CBC, liver function tests, hepatitis 
A, B and C virus for initial evaluation. All CBC and the other 
blood analyses were conducted within two hours of blood 
sampling in the central laboratory of the hospital. 
Demographic data, including maternal age, parity, ges-
tational week, BMI, and the laboratory data of the routine 
CBC parameters in the first evaluation of the patient were 
recorded. Gestational age was determined based on the first 
day of the last menstrual period (LMP) and first trimester 
ultrasonographic measurement of the crown–rump length 
(CRL). If ultrasound dating differed from LMP dating by 
more than seven days, the estimated date was changed to 
ultrasound dating [11]. Gestational age at delivery, birth 
weight (BW), Neonatal Intensive Care Unit (NICU) admis-
sion, meconium staining of amniotic fluid and APGAR score 
at 5 minutes were recorded for assessment of perinatal 
outcome. 
The data were analyzed using the Statistical Package 
for Social Sciences, Windows version 15.0 (SPSS, Chicago, IL, 
USA). Descriptive statistics were expressed as mean ± stand-
ard deviation and median (minimum-maximum) for nu-
merical variables. Normality of the data distribution was 
assessed with the Kolmogorov-Smirnov test. Statistical sig-
nificant differences between the groups were determined 
by Mann-Whitney U test with Bonferroni correction. Cat-
egorical variables were expressed as number (percentage). 
Proportions were compared with Fisher’s exact test or the 
chi-square test where appropriate. Associations between 
the variables were explored using the Pearson’s correlation 
analyses. Logistic regression analyses were performed to 
calculate odds ratios (OR) with 95% confidence intervals. A p 
value < 0.05 for were considered as statistically significant.
RESULTS 
A total of 180 pregnant (90 with ICP and 90 without 
disease) were included to the study. There were no statisti-
cally significant differences between groups according to 
age, parity, body mass index (BMI) and gestational week. 
Mean hemoglobin and hematocrit concentration, white 
blood cell count (WBC) and platelet count were also similar 
between groups. Mean Alanine Aminotransferase (ALT) and 
Aspartate Aminotransferase (AST) levels were significantly 
higher in ICP group. Demographic data and laboratory pa-
rameters of ICP and control group are presented in Table 1.
There were also no significant differences in age, parity 
and BMI between mild and severe groups. Mean hemo-
globin and hematocrit concentration, WBC and platelet 
count were also similar between mild disease and severe 
disease. Mean ALT level and mean fasting and postprandial 
Table 1. Demographic and laboratory characteristics of ICP and 
control group
Variables Control group(n = 90)
ICP group
(n = 90) P value
Age (years) 26.8 6.2 28.2 ± 5.3 0.103
GW at assessment 34.9 3.3 34.1 ± 3.6 0.121
Gravidity 2 (1–6) 2 (1–6) 0.108
Parity 1 (0–4) 0 (0–4) 0.051
BMI [kg/m²] 24.3 ± 1.2 23.8 ± 2.8 0.19
ALT [U/L] 16.5 ± 16 137 ± 118 0.0001
AST [U/L] 19.6 ± 8.8 94.1 ± 83.2 0.0001
Hemoglobin [g/dL] 11.5 ± 1.06 11.7 ± 1.1 0.168
Hemotocrit (%) 35.09 ± 2.4 35.9 ± 3.3 0.050
WBC × 103 mL 9.7 ± 2.1 10.4 ± 2.8 0.058
Platelets × 103 mL 231.1 ± 72.4 245.1 ± 64.2 0.175
RDW (%) 14.2 ± 1.7 15.2 ± 1.5 0.0003
Data expressed as mean ± SD. GW — gestational week; BMI — body mass 
ındex; ALT — alanine aminotransferase; AST — aspartate aminotransferase; 
WBC — white blood cell; RDW — red cell distribution width; ICP — intra-
hepatic cholestasis of pregnancy
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total bile acid concentration (TBA) levels were significantly 
higher in severe group. Demographic data and laboratory 
parameters of mild and severe ICP groups are showed in 
Table 2. 
In our study population mean RDW value was signifi-
cantly higher in pregnants with ICP (14.2 ± 1.7) than without 
disease (15.2 ± 1.5) (p = 0.003).There was also significant 
difference between pregnant with mild disease and severe 
disease (14.9 ± 1.6, 15.8 ± 1.1; p = 0.006 respectively) (Fig. 1). 
In correlation analyses in ICP group RDW was correlated with 
the fasting TBA (r = 0.231,p = 0.029) (Fig. 2) and postprandial 
TBA (r = 0.245,p = 0.024) (Fig. 3).
RDW was also positively and significantly correlated with 
ALT levels (r = 0.231, p = 0.001) and AST levels (r = 0.235, 
p = 0.001) in pregnant with ICP.
Table 2. Demographic and laboratory characteristics of mild and severe ICP group
Variables Mild group (n = 53) Severe group (n = 37) P value
Age (years) 28.1 ± 4.8 28.2 ± 5.8 0.981
GW at assessment 34.9 ± 2.3 32.9 ± 4.5 0.019
Gravidity 1 (1–6) 2 (1–6) 0.186
Parity 0 (0–4) 0 (0–2) 0.503
BMI [kg/m²] 24.1 ± 2.3 24.4 ± 1.8 0.35
ALT [U/L] 114.03 ± 109.3 169.4 ± 125.2 0.028
AST [U/L] 81.7 ± 82.2 112 ± 82.4 0.089
Fasting TBA [mmol/L] 21.3 ± 8.7 69.5 ± 70.7 0.0004
Postprandial TBA [mmol/L] 21.5 ± 12.7 68.9 ± 62 0.0001
Hemoglobin [g/dL] 11.7 ± 1.1 11.8 ± 1.2 0.734
Hemotocrit (%) 35.8 ± 3.0 36.1 ± 3.6 0.678
WBC × 103 mL 10.3 ± 3.0 10.4 ± 2.7 0.890
Platelets × 103 mL 245.4 ± 63.8 244.8 ± 65.6 0.967
RDW (%) 14.9 ± 1.6 15.8 ± 1.1 0.006
Data expressed as mean ± SD. GW — gestational week; BMI — body mass ındex; ALT — alanine aminotransferase; AST — aspartate aminotransferase; TBA — total bile 
acid concentration; WBC — white blood cell; RDW — red cell distribution width; ICP — intrahepatic cholestasis of pregnancy
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Figure 1. Comparison of RDW levels in the control, mild and severe 
ICP groups Figure 2. Correlation between RDW level and Fasting TBA (r = 0.231, 
p = 0.029)
Figure 3. Correlation between RDW level and Postprandial TBA  
(r = 0.245, p = 0.024)
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The perinatal outcomes of the pregnants with ICP and 
controls were presented in the Table 3. There were no cases 
of intrauterine fetal demise in any of the groups.BW and 
gestational age at birth were lower in the ICP group than the 
control group (p = 0.0005 and p = 0.0009, respectively) 
(Tab. 3). In Pearson correlation analyses in pregnant women 
with ICP, there were no correlation between RDW and BW 
and gestational age at birth(r = –0.067, p = 0.53; r = –0.068, 
p = 0.52; respectively). In subgroup analyses in pregnants 
with ICP; mean RDW levels were significantly higher in preg-
nants with meconium staining than without meconium 
staining (16.5 ± 1.3, 15.08 ± 1.4; p = 0.024 respectively). 
However there were no differences in RDW values in terms 
of other perinatal complications in pregnants complicated 
with ICP (Tab. 4). In logistic regression analyses when con-
sidering serum RDW value > 15.7 (%), the risk of meconium 
staining increased 6.4 fold (95% CI: 1.5–24.1; p = 0.011). 
DISCUSSION
In the present study we showed that RDW was signifi-
cantly higher in pregnants with ICP than healthy pregnant 
controls. It was also significantly higher in severe disease 
than mild disease in subgroup analyses. We have reported 
positive and significant correlation between serum RDW 
level and fasting and postprandial total bile acid concen-
tration and liver function tests in ICP patients. To the best 
of our knowledge this is the first study that evaluated and 
demonstrated an association between RDW level and ICP. 
The exact pathogenesis of ICP is unknown but associa-
tion between inflammation and disease has been previously 
reported in literature [7] .Elevated bile acid concentrations 
may lead to the release of several proinflammatory me-
diators and trigger inflammatory response in hepatocytes 
with infiltration of inflammatory cells into the liver [5, 12, 
13]. The activated inflammatory cells cause significant liver 
injury [13] and liver’s local intracellular response to inflam-
mation determines the clinical outcome and prognosis of 
the disease [7]. However the mechanism how cholestasis 
stimulates the production of proinflammatory mediators in 
the liver has not been completely understood yet. 
Recent studies demonstrated increased circulating levels 
of systemic and vascular inflammatory markers in pregnan-
cies with ICP [12, 14, 15]. Systemic inflammation can be meas-
ured by a variety of serum markers and it is indicated that 
hematological indices and ratio of blood cell subtypes in CBC 
might have been used as an inflammatory marker in many 
diseases. RDW, a hematological parameter in CBC, shows red 
blood cell size and it is routinely used for differential diagnosis 
of anemia [16]. In recent studies, it is reported that systemic 
inflammation may cause an increase in RDW and it can be 
used as an alternative diagnostic inflammation and oxidative 
stress marker in many diseases such as CVD, renal diseases, 
thrombotic and hypertensive disorders [9, 16] . Furthermore; 
Hu Z et al. found increased RDW levels and showed RDW 
as a potential prognostic marker in different types of liver 
disease such as liver cirrhosis after HBV infection, primary 
hepatocellular carcinoma, and primary biliary cirrhosis [17]. 
Inflammation may impair iron metabolism and can cause 
release of inflammatory cytokines that inhibit red cell matu-
ration and lead to immature erythrocytes to enter circula-
tion. This may explain the association between increased 
RDW levels and inflammation [18, 19]. Elevated level of RWD 
has also been found to be associated with poor outcome and 
independent marker of mortality in these patients [20, 21]. 
Table 3. The perinatal outcomes of control and ICP groups
Variables Control group (n = 90) ICP group (n = 90) P value
GW at delivery 38.1 ± 1.4 36.2 ± 1.8 0.0009
BW [g] 3165 ± 551 2845 ± 487 0.0005
BW < 10th percentile, n(%) 3 (3.3%) 4 (4.4%) 0.7
Meconium staining of AF, n(%) 10 (11.1%) 12 (13.3%) 0.64
5 minute APGAR ≤ 7, n(%) 3 (3.33%) 10 (11.1%) 0.044
NICU admission, n(%) 4 (4.4%) 12 (13.3%) 0.036
Data expressed as mean ± SD, number(%). GW — gestational week; BW — birth weight; AF — amniotic fluid; NICU — Neonatal Intensive Care Unit
Table 4. RDW values with perinatal complications in pregnants 
with ICP
RDW P value 
BW < 10th percentile(+) 14.7 ± .9
0.39
BW < 10th percentile(–) 15.3 ± 1.5
Meconium staining of AF(+) 16.5 ± 1.3
0.024
5 minute APGAR ≤ 7(+) 15.08 ± 1.4
5 minute APGAR ≤ 7(–)
16.1 ± 1.8
0.08
15.2 ± 1.4
NICU admission (+) 16.1 ± 1.8
0.08
NICU admission (–) 15.1 ± 1.4
Data expressed as mean ± SD. BW — birth weight; AF — amniotic fluid; NICU 
— Neonatal Intensive Care Unit 
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Systemic inflammation has been suggested to play a role 
in the etiology of certain obstetric complications such as 
preeclampsia, preterm delivery, and gestational diabetes 
[22, 23]. Erdoğan et al found no association between RDW 
levels and gestational diabetes mellitus [24]. Kurt et al. found 
that RDW was associated with preeclampsia and with se-
verity of the disease [25] .Otherwise Abdullahi et al could 
not find an association between serum RDW level and the 
presence of preeclampsia [26]. However, little is known and 
there is no study about if there is an association between 
RDW level and ICP. We found increased levels in pregnants 
complicated with ICP than healthy pregnants in our study.
ICP is associated with increased risk of preterm delivery, 
meconium passage, intrapartum fetal distress and stillbirth 
[27, 28]. Due to the high rates of stillbirth and neonatal 
complications early delivery is recommended for these preg-
nants [29]. In literature there are many studies about the 
predictors of adverse neonatal outcome in these patients 
however optimal outcome predictors and timing of delivery 
are unknown. Serum TBA level > 40mmol/L were found to 
be associated with increased risk of meconium staining, 
low APGAR scores and stillbirth in recent studies [30, 31]. 
We found lower BW and lower gestational age at birth in 
pregnants with ICP than healthy pregnants similar with 
the literature due to our policy of early delivery of these 
patients. Our findings also showed that high RDW levels 
were associated with the incidence of meconium staining 
in pregnants with ICP. 
CONCLUSIONS
In conclusion, the present study demonstrated an as-
sociation between that serum RDW level and ICP for the first 
time in literature. RDW, an easy, inexpensive and routinely 
reported parameter in a routinely performed CBC test might 
allow significant diagnostic and prognostic information in 
patients with ICP. However, further studies with large sample 
sizes are needed to understand the causative role of RDW 
in pregnants with ICP. 
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